2014 · 15 citations · 6 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryPharmaceutical FormulationCapsule BioavailabilityCapsule DissolutionCapsule FormulationDrug Release From Dosage FormsLipid-based Drug Delivery SystemsMedicinal PlantsCapsule Formulation DesignCapsule Release ProfilesControlled Drug ReleaseDrug Release MechanismsExtractOral Drug Delivery SystemsPhysicochemical Capsule CharacterizationZeta Potential Measurement
Objective of the present study was to formulate and evaluate capsules of Ashwagandha phytosomes. There are many herbal extracts having excellent in-vitro activity but less in-vivo activity because of their macromolecular size and poor lipid solubility, which result in poor absorption and bioavailability problems. Many of these problems can be overcome by formulating novel drug delivery systems. Phytosomes provide better absorption and bioavailability than the conventional herbal extracts. This project aims in improving the drug release characteristics of Ashwagandha by formulating Ashwagandha phytosome capsules. Ashwagandha Phytosomes were produced by a process in which standardized plant extract was bound to phospholipids, producing a lipid compatible molecular complex. Ashwagandha phytosome complexes were characterized by particle size, zeta potential, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy and in vitro drug release. The results showed that the average particle size and zeta potential of optimized Ashwagandha phytosomes formulation were 98.4nm and −28.7 mV. In vitro drug release studies revealed that the cumulative % drug release of capsules of Ashwagandha phytosomes was found to be 76.8%. Antioxidant activity of Ashwagandha phytosomes was evaluated by reducing power method. The results showed that the Ashwagandha phytosome complex exhibited more antioxidant activity compared to the Ashwagandha extract. Hence it was concluded that Ashwagandha phytosomes serve as useful novel drug delivery system and provide more bioavailability than conventional formulations.
6
Design and Evaluation of a Novel Evodiamine-Phospholipid Complex for Improved Oral Bioavailability
Qunyou Tan, Shan Liu, Xueliang Chen et al. · AAPS PharmSciTech · 2012 · 157 citations · Full text
Mechanisms of Phospholipid Complex Loaded Nanoparticles Enhancing the Oral Bioavailability
Qiang Peng, Zhirong Zhang, Xun Sun et al. · Molecular Pharmaceutics · 2010 · 91 citations
Preparation and properties of a silybin-phospholipid complex
Yunmei Song, Qineng Ping · Die Pharmazie · 2008 · 39 citations · Full text